





| Catalog No. | HV802046 |
|---|---|
| Description |
Efruxifermin (HV802046) is a research-grade recombinant antibody targeting Fibroblast growth factor 21. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Isotype | Human IgG1 Fc domain linked to a modified human FGF21. |
| Expression system | Mammalian cells |
| Target | Fibroblast growth factor 21, FGF-21, FGF21, UNQ3115/PRO10196 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | Q9NSA1 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | 2375240-92-7 |
| Background | Fibroblast growth factor 21 (FGF21) is a ~22 kDa protein. Stimulates glucose uptake in differentiated adipocytes via the induction of glucose transporter SLC2A1/GLUT1 expression (but not SLC2A4/GLUT4 expression). Activity requires the presence of KLB. Regulates systemic glucose homeostasis and insulin sensitivity. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com






+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский